Formycon mit Sitz in Martinsried bei München entwickelt biopharmazeutische Nachahmerprodukte für die Zulassung in Europa, USA und Japan. Biopharmazeutika (Antikörper) werden bei Krebs eingesetzt.
COMPANY
INVESTOR TERMSHEET
FYB
Formycon
#BGFL Mood:
-
·
#BGFL-Indicator:
-
·
Review date:
-
LEI:
39120005TZ76GQOY8Z19
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
NAME
Formycon
WKN
A1EWVY
ISIN
DE000A1EWVY8
TICKER
FYB
INDEX
SDAX
EXCHANGE
Xetra
#BGFL-nes Formycon: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.
| 19.12.2017 | Formycon: Nachahmung empfohlen |
| 27.03.2014 | Formycon: Unangenehme Kursschwankungen |
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
